Related Experiment Video
Updated: Aug 20, 2026
Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic
Alan Ebringer1, Lucy Hughes, Taha Rashid
1Division of Life Sciences, Infection and Immunity Group, Waterloo Campus, King's College, 150 Stamford Street, London SE1, England, UK. alan.ebringer@kcl.ac.uk
Abstract:
Multiple sclerosis (MS) is the most common cause of neurologic disability among young people. The etiology of MS is controversial, but immune responses are considered to somehow be involved. The diagnosis of MS depends on a combination of various clinical and laboratory features, but apart from some myelin-neuronal autoantibody profiles or oligoclonal bands in the cerebrospinal fluid no other serologic diagnostic test or marker has yet been discovered. However, the presence of antibodies to Acinetobacter species in MS patients opens the possibility of developing a composite laboratory diagnostic marker, the myelin-Acinetobacter-neurofilament index. Whether Acinetobacter is the triggering agent of MS remains to be determined, but the measurement of anti-Acinetobacter antibodies could be used as a marker of disease activity. To evaluate this, prospective randomized controlled studies should be performed with MS patients, especially in the early stages of the disease.
Insights
Multiple sclerosis (MS) diagnosis may be improved by a new composite marker. Measuring anti-Acinetobacter antibodies could indicate disease activity in multiple sclerosis patients.
Area of Science:
- Neurology
- Immunology
- Microbiology
Background:
- Multiple sclerosis (MS) is a leading cause of neurologic disability in young adults.
- Current MS diagnosis relies on clinical and laboratory findings, with limited serologic markers.
- The role of immune responses in MS etiology is recognized but not fully understood.
Purpose of the Study:
- To explore the potential of anti-Acinetobacter antibodies as a diagnostic marker for MS.
- To investigate the possibility of a novel composite diagnostic marker, the myelin-Acinetobacter-neurofilament index.
Main Methods:
- Analysis of antibody profiles in MS patients.
- Evaluation of Acinetobacter species' potential role in MS.
- Proposed development of a composite laboratory diagnostic marker.
Main Results:
- The presence of antibodies to Acinetobacter species in MS patients was identified.
- This finding suggests a potential for a new diagnostic marker.
Conclusions:
- Anti-Acinetobacter antibodies may serve as a marker for MS disease activity.
- Further prospective studies are needed to validate the myelin-Acinetobacter-neurofilament index for MS diagnosis and activity monitoring.
